Jeremy Graff
Chief Tech/Sci/R&D Officer at IMV INC.
Net worth: 5 413 $ as of 2024-05-30
Profile
Jeremy R.
Graff is currently an Independent Director at IN8bio, Inc. since 2023 and the Chief Scientific Officer at IMV, Inc. since 2021.
Previously, he served as the President & Chief Scientific Officer at Biothera Pharmaceutical, Inc. from 2018 to 2020.
He also held positions as the Chief Development Officer & Senior VP-Research at Hibercell, Inc. and as the President & Chief Scientific Officer at Biothera, Inc. Dr. Graff obtained his undergraduate degree from Thomas More University and his doctorate from the University of Kentucky.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IN8BIO, INC.
0.01% | 2024-06-11 | 4,549 ( 0.01% ) | 5 413 $ | 2024-05-30 |
IMV INC.
-.--% | 2023-03-19 | 0 ( -.--% ) | - $ | 2023-12-30 |
Jeremy Graff active positions
| Companies | Position | Start |
|---|---|---|
| IMV INC. | Chief Tech/Sci/R&D Officer | 2021-06-13 |
| IN8BIO, INC. | Director/Board Member | 2023-04-30 |
Former positions of Jeremy Graff
| Companies | Position | End |
|---|---|---|
Biothera, Inc.
 Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | President | 2020-05-31 |
Biothera Pharmaceutical, Inc.
 Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | President | 2020-05-31 |
Hibercell, Inc.
 Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Training of Jeremy Graff
| University of Kentucky | Doctorate Degree |
| Thomas More University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IMV INC. | Health Technology |
| IN8BIO, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Biothera, Inc. develops natural gluco polysaccharide that engages and directs natural innate immune systems. The company was founded by Daniel Conners in 1997 and is headquartered in Eagan, MN. | Commercial Services |
Biothera Pharmaceutical, Inc.
Biothera Pharmaceutical, Inc. Medical/Nursing ServicesHealth Services Biothera Pharmaceutical, Inc. operates as a biotechnology company. It develops Imprime PGG, a novel dectin receptor agonist that reverses tumor-mediated immunosuppression while promoting antigen presentation to drive T cell activation. The company was founded in 1997 and is headquartered in Roseville, MN. | Health Services |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Jeremy Graff
